Arkolith/Insider Trading/RNAZ/Form 4/A

Dudley Robert Michael

Chief Executive Officer, DirectorTranscode Therapeutics, Inc. (RNAZ) · full profile →Form 4/A · filed Jun 14, 2023
Net Buying
Open-Market Buys
$52K
Open-Market Sells
$0
Net Open-Market Flow
$52K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 9, 2023Buy(P)19K$2.76$52K61K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001104659-23-071204) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML